Financiere des Professionnels Fonds d investissement inc. Sells 1,328 Shares of Danaher Corporation (NYSE:DHR)

Financiere des Professionnels Fonds d investissement inc. trimmed its position in Danaher Corporation (NYSE:DHR - Free Report) by 4.0% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 32,170 shares of the conglomerate's stock after selling 1,328 shares during the period. Financiere des Professionnels Fonds d investissement inc.'s holdings in Danaher were worth $6,595,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in DHR. GHP Investment Advisors Inc. grew its holdings in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares in the last quarter. Heck Capital Advisors LLC bought a new position in Danaher in the 4th quarter valued at $27,000. Sierra Ocean LLC grew its stake in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in Danaher in the 1st quarter valued at $31,000. Finally, Rialto Wealth Management LLC bought a new position in Danaher during the fourth quarter valued at about $34,000. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president owned 15,179 shares in the company, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by company insiders.

Danaher Price Performance

Shares of DHR stock traded up $0.58 during trading hours on Friday, reaching $203.08. The stock had a trading volume of 1,390,744 shares, compared to its average volume of 3,499,704. The stock's fifty day simple moving average is $195.63 and its 200 day simple moving average is $207.23. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $281.70. The firm has a market capitalization of $145.33 billion, a PE ratio of 39.43, a PEG ratio of 2.85 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. On average, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher's dividend payout ratio is 24.85%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on DHR shares. Argus reduced their price target on shares of Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Bank of America reduced their target price on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Guggenheim reissued a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a report on Friday, March 14th. Finally, The Goldman Sachs Group reduced their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $248.61.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.